Search
Search Results
##search.searchResults.foundPlural##
-
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1409PDF: 817HTML: 365 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1616PDF: 1154HTML: 265 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3803PDF: 939HTML: 6880 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3874PDF: 1652HTML: 866Figures . Eliassian: 256 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3357PDF: 974HTML: 3312 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3002PDF: 1323HTML: 2835Figure 1: 201 -
Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
1537PDF: 758HTML: 4596Figure 1: Chest radiograph: 238Figure 2: Flow cytometer analysis of pleural fluid: 208 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1337PDF: 892HTML: 267 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
769PDF: 484HTML: 6286 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2300PDF: 1015HTML: 1985 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1916PDF: 840HTML: 232 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4168PDF: 1202HTML: 2110Fig.1: 232Fig. 2: 127Table 1: 227Table2: 246Table 3: 226 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4488PDF: 1804HTML: 1124 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3925PDF: 1729HTML: 11847Figures Haase: 239 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3730PDF: 2605HTML: 1637 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1279PDF: 627HTML: 6930 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1438PDF: 619Suppl. Files: 376HTML: 175 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1508PDF: 929HTML: 1965 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3467PDF: 2047HTML: 7575 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3510PDF: 1337HTML: 2344Fi.1 Gritti.Rambaldi: 236 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2546PDF: 920HTML: 2571 -
-
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1502PDF: 969HTML: 255







